Crossover Fund Associate
Pura Vida Investments, LLC
New York, NY
Pura Vida is seeking a professional with scientific expertise and business acumen to evaluate private companies and technologies in both the life science tools and diagnostics subsector and medical technology subsector in a healthcare crossover fund. The fund will pursue investments across all sectors of the healthcare industry, including medical technology/products, genomics, HCIT/digital health, and biopharma. There is flexibility in the stage of development of companies of interest, but the primary focus is on later stage private healthcare companies. This professional will play a pivotal role in the evaluation of new opportunities and in the ongoing performance monitoring of the entire portfolio and will have the opportunity to regularly interact with portfolio company senior management teams and co-investors.
Source and evaluate crossover opportunities, while integrating technological, clinical, financial, and competitive landscapes. Launch independent research across the subsectors while engaging CEOs, sell-side analysts, and key opinion leaders. Understand industry trends as well as competitive dynamics, and incorporate analyses to determine the investment thesis and viability of the investment opportunity.
Ideal Qualifications & Experience
M.D or Ph.D. in Biochemistry, Biology, Cell Biology, Genomics, Immunology, Molecular Genetics and Microbiology, Computational Biology, Neurobiology, Pathology, Pharmacology, Cancer Biology, Microelectronics, Biochemical or Biomedical Engineering, or similar field. Insights into proteomics, genomics, molecular diagnostics, molecular biology, or sequencing, with the ability to think broadly and communicate clearly and concisely about the underlying science. Venture capital, private equity, buy side or sell side equity research experience, consulting or business development background is ideal.
About Pura Vida
Founded in 2012, Pura Vida is a healthcare-focused hedge fund with a market-neutral approach. Since inception, the firm has generated superior returns and was named Best Long/Short Manager by Institutional Asset Management Awards hosted by HFM Global and Pension Bridge in 2019. The firm invests across the healthcare sector, including medical technology and devices, tools and diagnostics, biotechnology, pharmaceuticals, and healthcare services.
Pura Vida provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.